Fadista, João
Skotte, Line http://orcid.org/0000-0002-7398-1271
Karjalainen, Juha
Abner, Erik http://orcid.org/0000-0002-6529-3161
Sørensen, Erik
Ullum, Henrik
Werge, Thomas http://orcid.org/0000-0003-1829-0766
Werge, Thomas
Hougaard, David M.
Børglum, Anders D.
Nordentoft, Merete
Mortensen, Preben B.
Esko, Tõnu
Milani, Lili http://orcid.org/0000-0002-5323-3102
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Daly, Mark
Melbye, Mads http://orcid.org/0000-0001-8264-6785
Feenstra, Bjarke http://orcid.org/0000-0003-1478-649X
Geller, Frank http://orcid.org/0000-0002-9238-3269
,
,
Funding for this research was provided by:
Oak Foundation
Carlsbergfondet (CF15-0899)
Article History
Received: 7 May 2021
Accepted: 18 May 2022
First Online: 9 June 2022
Competing interests
: J.F. currently works for Novo Nordisk A/S. The remaining authors declare no competing interests.